Grand Mount Capital (GMC) establishes in-depth cooperation with multiple listed companies and healthcare conglomerates.
Grand Mount Capital (GMC) is a dedicated healthcare venture capital firm established by state-owned capital and investment professionals in 2019. GMC’s investment spans biopharmaceuticals, medical devices, and diagnostics. Adhering to the strategy of “Industry participation+ capital assistance", GMC works closely with multiple healthcare conglomerates to add value to portfolio companies by providing active support in market access, collaborations, regulatory guidance, etc. GMC aims to deliver long-term and sustainable return for investors while becoming a trusted partner to entrepreneurs that aim to build great companies with breakthrough technologies.
Learn moreBiopharmaceuticals; Medical Devices; Healthcare services
GMC’s team includes experienced professionals with expertise in the healthcare industry, investment institutions, accounting, and law firms.
Learn about the latest news
Congratulation to Coyotebio for being named Top 30 of the most growing enterprises in China’s e...
Coyotebio’s Flash20TM rapid detection solution against COVID-19 has been widely broadcaste...
Health Biotech has completed series B financing of hundreds of millions RMB, cementing its lea...